Brett Mahon

Title: Brett Mahon: Innovator in Histology and Nucleic Acid Analysis

Introduction

Brett Mahon is a notable inventor based in Chicago, IL (US), recognized for his contributions to the field of histology and nucleic acid analysis. With a total of 4 patents to his name, Mahon has developed innovative methods that enhance the quality and efficiency of specimen analysis in medical research.

Latest Patents

Mahon's latest patents include groundbreaking methods for predicting total nucleic acid yield and dissection boundaries for histology slides. One of his patents provides a method for qualifying a specimen prepared on hematoxylin and eosin (H&E) slides by assessing the expected yield of nucleic acids for tumor cells. This method also includes providing associated unstained slides for subsequent nucleic acid analysis. Another patent focuses on determining tumor block sufficiency for generating H&E slides by assessing the expected yield of nucleic acids for tumor cells and determining the number of H&E slides needed to satisfy a desired total nucleic yield.

Career Highlights

Throughout his career, Brett Mahon has worked with prominent companies such as Tempus Labs, Inc. and Tempus AI, Inc. His work has significantly impacted the field of histology, particularly in improving the accuracy and reliability of nucleic acid analysis.

Collaborations

Mahon has collaborated with talented professionals in his field, including Stephen Yip and Irvin Ho. These collaborations have furthered his research and development efforts, leading to innovative solutions in histology.

Conclusion

Brett Mahon is a distinguished inventor whose work in histology and nucleic acid analysis has made significant contributions to medical research. His innovative patents and collaborations reflect his commitment to advancing the field and improving diagnostic methods.